ESRRG | Estrogen-related receptor gamma | FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
ETNK2 | Ethanolamine kinase 2 | Enzymes
| | | | | Tissue enhanced |
EXOC3L2 | Exocyst complex component 3-like 2 | | | | | | Tissue enhanced |
FAM131C | Family with sequence similarity 131, member C | | | | | | Tissue enhanced |
FCAMR | Fc receptor, IgA, IgM, high affinity | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
FGF9 | Fibroblast growth factor 9 | Cancer-related genes Disease related genes RAS pathway related proteins
| | | | | Tissue enhanced |
FLRT3 | Fibronectin leucine rich transmembrane protein 3 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
FMO4 | Flavin containing monooxygenase 4 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
FOXC2 | Forkhead box C2 (MFH-1, mesenchyme forkhead 1) | Disease related genes Transcription factors
| | | | | Tissue enhanced |
FOXI1 | Forkhead box I1 | Plasma proteins Transcription factors
| | | | | Tissue enhanced |
FOXI2 | Forkhead box I2 | Transcription factors
| | | | | Tissue enhanced |
FREM2 | FRAS1 related extracellular matrix protein 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
FUT6 | Fucosyltransferase 6 (alpha (1,3) fucosyltransferase) | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
FXYD6-FXYD2 | FXYD6-FXYD2 readthrough | Predicted membrane proteins
| | | | | Tissue enhanced |
G6PC | Glucose-6-phosphatase, catalytic subunit | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
GGT1 | Gamma-glutamyltransferase 1 | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GGT2 | Gamma-glutamyltransferase 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
GGTLC2 | Gamma-glutamyltransferase light chain 2 | | | | | | Tissue enhanced |
GLIS1 | GLIS family zinc finger 1 | Transcription factors
| | | | | Tissue enhanced |
GPR110 | G protein-coupled receptor 110 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GSTA1 | Glutathione S-transferase alpha 1 | Enzymes Plasma proteins
| | | | | Tissue enhanced |
GSTA2 | Glutathione S-transferase alpha 2 | Enzymes
| | | | | Tissue enhanced |
HAVCR1 | Hepatitis A virus cellular receptor 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
HECW1 | HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 | | | | | | Tissue enhanced |
HGD | Homogentisate 1,2-dioxygenase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
HNF1A | HNF1 homeobox A | Cancer-related genes Disease related genes Transcription factors
| | | | | Tissue enhanced |
HNF1B | HNF1 homeobox B | Disease related genes Transcription factors
| | | | | Tissue enhanced |
HOGA1 | 4-hydroxy-2-oxoglutarate aldolase 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Tissue enhanced |
HOXA9 | Homeobox A9 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
HOXB6 | Homeobox B6 | Transcription factors
| | | | | Tissue enhanced |
HOXB8 | Homeobox B8 | Transcription factors
| | | | | Tissue enhanced |
HOXC10 | Homeobox C10 | Transcription factors
| | | | | Tissue enhanced |
HOXD10 | Homeobox D10 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
HOXD8 | Homeobox D8 | Transcription factors
| | | | | Tissue enhanced |
HPN | Hepsin | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
HSD11B2 | Hydroxysteroid (11-beta) dehydrogenase 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
HSD17B14 | Hydroxysteroid (17-beta) dehydrogenase 14 | | | | | | Tissue enhanced |
IL17RB | Interleukin 17 receptor B | Predicted membrane proteins
| | | | | Tissue enhanced |
INSRR | Insulin receptor-related receptor | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
IRX1 | Iroquois homeobox 1 | Plasma proteins Transcription factors
| | | | | Tissue enhanced |
KCNH6 | Potassium voltage-gated channel, subfamily H (eag-related), member 6 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNJ15 | Potassium inwardly-rectifying channel, subfamily J, member 15 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
KIF12 | Kinesin family member 12 | | | | | | Tissue enhanced |
KLHDC7A | Kelch domain containing 7A | | | | | | Tissue enhanced |
KLRG2 | Killer cell lectin-like receptor subfamily G, member 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
KMO | Kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enhanced |
LGSN | Lengsin, lens protein with glutamine synthetase domain | | | | | | Tissue enhanced |
LIME1 | Lck interacting transmembrane adaptor 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
LRP2 | Low density lipoprotein receptor-related protein 2 | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LRRC19 | Leucine rich repeat containing 19 | Predicted membrane proteins
| | | | | Tissue enhanced |